FDA OK’s GSK’s asthma biologic for rare autoimmune disease
admin 13th December 2017 Uncategorised 0GlaxoSmithKline’s biologic Nucala has become the first therapy specifically approved in the US to treat a rare disease called eosinophilic granulomatosis with polyangiitis (EPGA).
More: FDA OK’s GSK’s asthma biologic for rare autoimmune disease
Source: News